Edition:
United States

Orpea SA (ORP.PA)

ORP.PA on Paris Stock Exchange

99.50EUR
29 May 2017
Change (% chg)

-- (--)
Prev Close
€99.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
103,444
52-wk High
€100.15
52-wk Low
€67.21

Latest Key Developments (Source: Significant Developments)

Orpea Q1 revenue rises by 10.5 pct to 751.7 million euros
Tuesday, 2 May 2017 12:36pm EDT 

May 2 (Reuters) - Orpea SA ::Strong growth of 10.5 pct in Q1 2017 revenue to EUR 751.7 million.For 2017 confirms revenue target of EUR 3,125 million ($3.41 billion) (up by 10 percent versus 2016).  Full Article

Orpea announces two acquisitions in Czech Republic and Austria
Tuesday, 18 Apr 2017 11:45am EDT 

April 18 (Reuters) - Orpea SA ::Announces two major acquisitions in the Czech Republic and Austria.Acquires Anavita, operator of nursing homes in the Czech Republic.Acquires Dr. Dr. Wagner group, operating in the Austrian market for healthcare institutions.  Full Article

Orpea FY recurring EBITDA up 18.5 pct to 475 million euros
Tuesday, 28 Mar 2017 12:30pm EDT 

Orpea SA : FY revenue revenues up 18.8 pct to 2,841 million euros ($3.08 billion) . FY recurring EBITDA up 18.5 pct to 475 million euros . FY net income group share 257.6 million euros versus 153.3 million euros year ago . FY real-estate portfolio up 18.7 pct to 4.1 billion euros . 9,313 beds added over the past year . To propose a dividend or 1.0 euro per share . For 2017 reiterates its revenue target of 3,125 million euros, a 10 pct increase on 2016, without factoring in the impact of any new developments, with the operating margin remaining consistently firm .Dr Jean-Claude Marian is retiring as chairman, and Philippe Charrier has been appointed non-executive chairman.  Full Article

Orphee makes impairment on Diesse Diagnostica Senese shares
Friday, 17 Mar 2017 02:58am EDT 

Orphee SA : Said on Thursday that it made an impairment of 4.3 million CHF ($4.32 million) on Diesse Diagnostica Senese S.p.A. (Diesse Diagnostica Senese) shares .The impairment to impact FY 2016 net result, but will not affect on FY 2016 EBITDA.  Full Article

Orpea Q4 revenue up 13.5 pct at 736.6 mln euros
Tuesday, 7 Feb 2017 12:18pm EST 

Orpea SA : Q4 revenue 736.6 million euros ($787.9 million) versus 649.0 million euros a year ago .2017 revenue seen at 3.13 billion euros (+10 percent).  Full Article

Orpea H1 EBITDAR up 21.4 pct at 368.5 million euros
Wednesday, 28 Sep 2016 01:00am EDT 

Orpea SA : H1 EBITDAR up 21.4 pct to 368.5 million euros ($413.16 million) . H1 attributable net profit 75.5 million euros versus 67.4 million euros year ago .2016 guidance reiterated.  Full Article

Orpea Q2 revenue rises 19.8% to 700.4 million euros
Wednesday, 20 Jul 2016 01:00am EDT 

Orpea SA : Q2 revenue EUR 700.4 million ($771.42 million) versus EUR 584.4 million year ago . H1 revenue growth of 23.0% to EUR 1.38 billion .Lifts 2016 revenue target by EUR 90 million to EUR 2.81 billion (growth of 17.5% versus 13.7% previously).  Full Article

Orpea acquires Sanyres group in Spain, issues new schuldschein
Tuesday, 5 Jul 2016 01:04am EDT 

Orpea SA : Acquisition of the Sanyres group in Spain: 18 facilities, 3,300 beds . Sanyres posted revenues of around 55 million euros ($61.2 million) in 2015 . Accretive impact on EPS from 2016 . Acquisition has been paid for entirely from group's cash position .Also announced a new schuldschein issue raising 277 million euros.  Full Article

Orpea confirms FY 2016 guidance
Wednesday, 4 May 2016 01:00am EDT 

Orpea SA:We comfortably reiterate our 2016 revenue target of 2,720 million euros(+13.7 pct), not including any additional developments.FY 2016 revenue: 2,754 million euros - Thomson Reuters I/B/E/S.  Full Article

Orpea comments on FY 2016 guidance, proposes FY 2015 dividend of 0.90 euros/share
Wednesday, 30 Mar 2016 01:00am EDT 

Orpea SA:Proposes FY 2015 dividend of 0.90 euro per share.2016 revenue target of 2,720 million euros (+13.7%) and solid profitability.  Full Article

More From Around the Web

BRIEF-Orpea Q1 revenue rises by 10.5 pct to 751.7 million euros

* Strong growth of 10.5 pct in Q1 2017 revenue to EUR 751.7 million